HC Wainwright Reaffirms Buy Rating for Clearside Biomedical (NASDAQ:CLSD)
Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $6.00 price target on the stock. CLSD has been the subject of a number of other research reports. Needham & Company LLC cut their price target on shares […]
Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $6.00 price target on the stock. CLSD has been the subject of a number of other research reports. Needham & Company LLC cut their price target on shares […]
